Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index; 10 of the 41 sources its claims cite were checked for support.
Abstract
This randomized, placebo-controlled, crossover, and double-blind trial aimed to examine the possible effects of four weeks L-theanine administration on stress-related symptoms and cognitive functions in healthy adults. Participants were 30 individuals (nine men and 21 women; age: 48.3 ± 11.9 years) who had no major psychiatric illness. L-theanine (200 mg/day) or placebo tablets were randomly and blindly assigned for four-week administration. For stress-related symptoms, Self-rating Depression Scale, State-Trait Anxiety Inventory-trait, and Pittsburgh Sleep Quality Index (PSQI) scores decreased after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively). The PSQI subscale scores for sleep latency, sleep disturbance, and use of sleep medication reduced after L-theanine administration, compared to the placebo administration (all p < 0.05). For cognitive functions, verbal fluency and executive function scores improved after L-theanine administration (p = 0.001 and 0.031, respectively). Stratified analyses revealed that scores for verbal fluency (p = 0.002), especially letter fluency (p = 0.002), increased after L-theanine administration, compared to the placebo administration, in individuals who were sub-grouped into the lower half by the median split based on the mean pretreatment scores. Our findings suggest that L-theanine has the potential to promote mental health in the general population with stress-related ailments and cognitive impairments.
Overview
CoChat Summary
TL;DR
In a randomized, placebo-controlled, double-blind crossover trial of 30 healthy adults, four weeks of L-theanine (200 mg/day) improved some stress-related symptom scores and cognitive scores, especially verbal fluency in participants with lower baseline performance. L-theanine was safe and well tolerated, but effects versus placebo were limited to certain PSQI subscales and verbal fluency.
Key findings
- SDS, STAI-trait, and PSQI scores decreased after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively); PSQI sleep latency and daytime dysfunction also improved (p = 0.036 and 0.022), with no significant changes after placebo.
- Compared with placebo, reductions were greater for PSQI sleep latency, sleep disturbance, and use of sleep medication (p = 0.0499, 0.046, and 0.047), while SDS and PSQI changes showed non-significant trends (p = 0.084 and 0.073).
- BACS verbal fluency and executive function improved after L-theanine (p = 0.001 and 0.031); in the lower half by median split, verbal fluency and letter fluency improved more than placebo (both p = 0.002), with executive function trending (p = 0.062).
- Serum L-theanine increased after L-theanine (p = 0.002) and differed from placebo (p = 0.028); no other biochemical indices changed significantly, and no adverse events or dropouts occurred.
Methods
- Thirty adults (9 men, 21 women; mean age 48.3 ± 11.9 years, range 20–69) without major psychiatric illness were randomized to 200 mg/day L-theanine or placebo before sleep for four weeks, then crossed over after a two-week washout.
- Assessments at baseline and weeks 4, 6, and 10 included SDS, STAI, PSQI, Trail-Making Test, Stroop test, BACS, and blood/saliva laboratory measures including serum L-theanine.
- Within-condition changes used Wilcoxon signed-rank tests; between-condition changes used Mann-Whitney U tests with r effect sizes; BACS scores were stratified by median split of mean pretreatment scores; two-tailed p < 0.05 was significant.
Limitations
- The paper states: real-world setting with unaccounted biases (tea consumption, medicine, diet, nutrients, work); only about 20% of symptom and cognitive measures changed significantly versus placebo, suggesting limited daily-function effects; participants had no psychiatric disorders, so effects may be inconspicuous; small n = 30 may be insufficient and subject to type II errors; wider age range and both sexes were included due to lack of solid information on specific subgroups.
- The paper also notes that compliance was checked only verbally and usual green tea or other L-theanine-containing beverage intake was not tracked.
- Evident from the text: no correction for multiple comparisons is reported, and Trail Making Test A and B improved significantly after placebo (p = 0.042 and 0.038), which complicates attribution of cognitive changes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
8 Valid · 1 Not valid · 4 Not checked · 58 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“To our knowledge, however, only its acute effects have been investigated in healthy individuals.”
- Also stated in: § 1. Introduction · plain
“With the except of Hidese et al. [40], most human studies have focused on the effects of acute L-theanine administration.”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [33] Kimura, 2007, l-theanine reduces psychological and physiological stress responses, Biol. Psychol. source
- Disputedcites [34] White, D.J., de Klerk, S., Woods, W., Gondalia, S., Noonan, C., and Scholey, A.B. (2016). Anti-stress, behavioural and magnetoencephalography effects of an l-theanine-based nutrient drink: A randomised, double-blind, placebo-controlled, crossover trial. Nutrients, 8. sourceExperimental — accuracy not yet measured
The Discussion (page not specified) explicitly reports a study of chronic l-theanine administration in undergraduate students, including a one-week run-in. That contradicts the claim that only acute effects have been investigated in healthy individuals. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [35] Unno, 2013, Anti-stress effect of theanine on students during pharmacy practice: Positive correlation among salivary α-amylase activity, trait anxiety and subjective stress, Pharmacol. Biochem. Behav. source
- Not checked — no full text of the sourcecites [36] Foxe, 2012, Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task, Neuropharmacology source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. Introduction · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“The current sample (30 L-theanine and 30 placebo) had a power of> 0.80, based on the effect size (0.61) of L-theanine on depression score in our previous study [40].”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > 2. Materials and Methods > 2.1. Participants
What the sources say
- Supportedcites [40] Hidese, 2017, Effects of chronic l-theanine administration in patients with major depressive disorder: An open-label study, Acta Neuropsychiatr. source
The Results report an effect size of r = −0.61 for the decrease in HAMD-21 depression scores, supporting the previous-study value cited. The 30-per-group sample and >0.80 power are calculations about the citing study, not findings attributed to this source. (LLM, conf=0.92)
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In accordance with this, we have reported multiple favourable effects of four weeks L-theanine administration (250 mg/day) in patients with major depressive disorder (MDD), although this was an open-label study [40].”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > 1. Introduction
What the sources say
- Partly supportedcites [40] Hidese, 2017, Effects of chronic l-theanine administration in patients with major depressive disorder: An open-label study, Acta Neuropsychiatr. sourceExperimental — accuracy not yet measured
The L-theanine administration section describes an open-label study in patients with MDD using 250 mg/day, and the Discussion reports multiple favourable effects. But treatment lasted eight weeks, not four; the Statistics section says the reported comparisons were between baseline and eight weeks. Four-week measurements were recorded, but they do not support describing this as a four-week study. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition to the possible efficacy in the treatment of clinical depression [40], the present study suggests that L-theanine may be a psychoactive reagent broadly useful to improve mental health in humans.”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > 4. Discussion
What the sources say
- Supportedcites [40] Hidese, 2017, Effects of chronic l-theanine administration in patients with major depressive disorder: An open-label study, Acta Neuropsychiatr. source
The citation is attached to the possible efficacy of L-theanine for clinical depression, not to the citing authors’ broader conclusion about mental health. In the Discussion, the source reports reduced depressive symptoms after L-theanine administration in patients with major depressive disorder, while noting that its study was open-label and the reduction was seen in patients unremitted at baseline. That supports the citing sentence’s qualified wording, “possible efficacy.” (LLM, conf=0.92)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Stratified analyses revealed that scores for verbal fluency (p = 0.002), especially letter fluency (p = 0.002), increased after L-theanine administration, compared to the placebo administration, in individuals who were sub-grouped into the lower half by the median split based on the mean pretreatment scores.”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
41 more claims
Create a free account to see all 71 claims and every source verdict.
- It may state two separate claims as one. 15
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, a randomized, double-blind, placebo-controlled, crossover trial involving healthy Japanese adults (n = 30) reported that supplementation with 200 mg/day of L-theanine for four weeks was associated with a significant reduction in participant-reported mood and anxiety symptoms relative to baseline that did not occur during the placebo condition, though between group analyses showed only”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have also reported this dosing range of L-theanine to be safe and well-tolerated.”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overall, trials have indicated that supplementation with 200–400 mg/day of L-theanine can help to reduce both perceived and physiological markers of stress and anxiety in largely healthy adult samples, particularly during periods of acute stress.”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similar improvement of sleep was observed in healthy participants' sleep disturbance shown as decreased scores of PSQI (P = 0.030) [8], as well as in participants diagnosed with GAD [4].”
From How does the tea L-theanine buffer stress and anxiety (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Other studies examining l-theanine have also shown improvements in markers of stress among healthy populations in acute [9, 10] and chronic [11, 12] settings.”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971 · cited 2×
“The sample size was determined by using G*Power software (3.1 version, Franz Faul, University of Kiel, Kiel, Germany) [41,42].”
InfluentialStatistical power analyses using G∗Power 3.1: tests for correlation and regression analyses
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615 · cited 2×
“The sample size was determined by using G*Power software (3.1 version, Franz Faul, University of Kiel, Kiel, Germany) [41,42].”
InfluentialThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234 · cited 8×
“The SDS, STAI-trait (T), and PSQI scores were significantly improved after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively; Figure 1).”
MethodInfluential(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
(1998) · PubMed · Cited by 10,216
Keefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573 · cited 1×
“Cognitive functions were evaluated by a research psychiatrist using the Trail-Making Test [57], the Stroop test [58], and the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS) [59,60].”
MethodAdministration and interpretation of the Trail Making Test
Bowie, C. R., & Harvey, P. D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.390 · Cited by 1,418 · cited 1×
“Cognitive functions were evaluated by a research psychiatrist using the Trail-Making Test [57], the Stroop test [58], and the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS) [59,60].”
MethodSelf-Rating Depression Scale in an Outpatient Clinic: Further Validation of the SDS
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060026004 · Cited by 1,068 · cited 5×
“The SDS, STAI-trait (T), and PSQI scores were significantly improved after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively; Figure 1).”
MethodInfluentialDoi, Y., Minowa, M., Uchiyama, M., Okawa, M., Kim, K., Shibui, K., & Kamei, Y. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00232-8 · Cited by 992 · cited 8×
“The SDS, STAI-trait (T), and PSQI scores were significantly improved after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively; Figure 1).”
MethodInfluentialReliability and validity of Japanese version of the Mini‐International Neuropsychiatric Interview
OTSUBO, T., TANAKA, K., KODA, R., SHINODA, J., SANO, N., TANAKA, S., AOYAMA, H., MIMURA, M., & KAMIJIMA, K. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01408.x · Cited by 507 · cited 1×
“Individuals who had been treated for any psychiatric disorder, assessed according to the criteria of the Japanese version of the Mini-International Neuropsychiatric Interview [43,44] and the Diagnostic and Statistical Manual of Mental Disorders, 5th edition [45], were excluded.”
MethodCONSORT for reporting randomised trials in journal and conference abstracts
Hopewell, S., Clarke, M., Moher, D., Wager, E., Middleton, P., Altman, D. G., & Schulz, K. F. (2008) · The Lancet · doi:10.1016/s0140-6736(07)61835-2 · Cited by 458 · cited 1×
“This randomized study adhered to the Consolidated Standards of Reporting Trials extensions [47].”
l-theanine reduces psychological and physiological stress responses
Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2006.06.006 · Cited by 349 · cited 2×
“The anti-stress effects of L-theanine (200 mg/day) have been observed following once- [33,34] and twice daily [35] administration, while its attention-improving effects have been observed in response to treatment of 100 mg/day on four separate days [36] and 200 mg/day single administration [37], which was further supp…”
BackgroundResultInfluentialSelf-citationBrief Assessment of Cognition in Schizophrenia: Validation of the Japanese version
KANEDA, Y., SUMIYOSHI, T., KEEFE, R., ISHIMOTO, Y., NUMATA, S., & OHMORI, T. (2007) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01725.x · Cited by 255 · cited 1×
“Cognitive functions were evaluated by a research psychiatrist using the Trail-Making Test [57], the Stroop test [58], and the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS) [59,60].”
MethodSaeed, M., Naveed, M., Arif, M., Kakar, M. U., Manzoor, R., Abd El-Hack, M. E., Alagawany, M., Tiwari, R., Khandia, R., Munjal, A., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.024 · Cited by 240
Bioactive components of tea: Cancer, inflammation and behavior
de Mejia, E. G., Ramirez-Mares, M. V., & Puangpraphant, S. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.02.013 · Cited by 231 · cited 1×
“However, the dose was relatively high compared to the median amount of L-theanine per cup of green tea (8–30 mg) [49].”
BackgroundYokogoshi, H., Kobayashi, M., Mochizuki, M., & Terashima, T. (1998) · Neurochemical Research · doi:10.1023/a:1022490806093 · Cited by 229
Green tea effects on cognition, mood and human brain function: A systematic review
Mancini, E., Beglinger, C., Drewe, J., Zanchi, D., Lang, U. E., & Borgwardt, S. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.07.008 · Cited by 215
L-Theanine, Unique Amino Acid of Tea, and Its Metabolism, Health Effects, and Safety
Türközü, D., & Şanlier, N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1016141 · Cited by 207 · cited 1×
“In humans, L-theanine has been reported to modulate alpha activity and play a role in attentional tasks in electroencephalogram studies [28–30], as well as provide beneficial effects on mental state [31], including sleep quality [32].”
BackgroundCamfield, D. A., Stough, C., Farrimond, J., & Scholey, A. B. (2014) · Nutrition Reviews · doi:10.1111/nure.12120 · Cited by 155
(2008) · PubMed · Cited by 154
Epidemiological Evidence Linking Tea Consumption to Human Health: A Review
Vuong, Q. V. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.594184 · Cited by 148
l-Theanine: An astounding sui generis integrant in tea
Sharma, E., Joshi, R., & Gulati, A. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.09.046 · Cited by 125
Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction
Kakuda, T. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.03.010 · Cited by 124 · cited 1×
“As the structure of L-theanine resembles that of L-glutamic acid, its mechanism of action may be potentially mediated through glutamate receptors [4], a possibility supported by its partial co-agonistic effect on the N-methyl-D-aspartate receptor [5,6].”
BackgroundAnalyzing Variability in Nectar Amino Acids: Composition Is Less Variable Than Concentration
Gardener, M. C., & Gillman, M. (2001) · Journal of Chemical Ecology · doi:10.1023/a:1013687701120 · Cited by 119 · cited 1×
“Serum L-theanine concentrations were measured using a high-performance liquid chromatography system based on the AccQ·Tag method [61], using commercially available reagents (Waters Corp.”
MethodTERASHIMA, T., TAKIDO, J., & YOKOGOSHI, H. (1999) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.63.615 · Cited by 112 · cited 1×
“Peripherally and centrally administered L-theanine has been reported to act on the brain [12,13], to modulate monoamine levels in the central nervous system [14–17], and glutamate and glycine neurotransmissions [18,19].”
BackgroundFoxe, J. J., Morie, K. P., Laud, P. J., Rowson, M. J., de Bruin, E. A., & Kelly, S. P. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.020 · Cited by 106 · cited 1×
“The anti-stress effects of L-theanine (200 mg/day) have been observed following once- [33,34] and twice daily [35] administration, while its attention-improving effects have been observed in response to treatment of 100 mg/day on four separate days [36] and 200 mg/day single administration [37], which was further supp…”
BackgroundInfluentialKIMURA, R., & MURATA, T. (1971) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.19.1257 · Cited by 98 · cited 1×
“Peripherally and centrally administered L-theanine has been reported to act on the brain [12,13], to modulate monoamine levels in the central nervous system [14–17], and glutamate and glycine neurotransmissions [18,19].”
BackgroundGomez-Ramirez, M., Higgins, B. A., Rycroft, J. A., Owen, G. N., Mahoney, J., Shpaner, M., & Foxe, J. J. (2007) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000240940.13876.17 · Cited by 96
Lardner, A. L. (2014) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000079 · Cited by 92 · cited 1×
“Moreover, L-theanine has been suggested to have potential therapeutic effects in psychiatric disorders [39].”
BackgroundGreen tea and theanine: Health benefits
Cooper, R. (2012) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2011.629180 · Cited by 90
Gomez-Ramirez, M., Kelly, S. P., Montesi, J. L., & Foxe, J. J. (2009) · Brain Topography · doi:10.1007/s10548-008-0068-z · Cited by 90
White, D., De Klerk, S., Woods, W., Gondalia, S., Noonan, C., & Scholey, A. (2016) · Nutrients · doi:10.3390/nu8010053 · Cited by 85 · cited 2×
“The anti-stress effects of L-theanine (200 mg/day) have been observed following once- [33,34] and twice daily [35] administration, while its attention-improving effects have been observed in response to treatment of 100 mg/day on four separate days [36] and 200 mg/day single administration [37], which was further supp…”
BackgroundResultInfluentialAcute effects of tea consumption on attention and mood
Einöther, S. J. L., & Martens, V. E. G. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.058248 · Cited by 84
Theanine-induced reduction of brain serotonin concentration in rats
YOKOGOSHI, H., MOCHIZUKI, M., & SAITOH, K. (1998) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.62.816 · Cited by 83
Hidese, S., Ota, M., Wakabayashi, C., Noda, T., Ozawa, H., Okubo, T., & Kunugi, H. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.33 · Cited by 81 · cited 9×
“In addition to the possible efficacy in the treatment of clinical depression [40], the present study suggests that L-theanine may be a psychoactive reagent broadly useful to improve mental health in humans.”
BackgroundResultInfluentialSelf-citationYamada, T., Terashima, T., Okubo, T., Juneja, L. R., & Yokogoshi, H. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500170799 · Cited by 72 · cited 2×
“The modulation of the monoamine [14–17] and glutamic acid and glycine [18,19] systems may also contribute to these four weeks psychotropic effects.”
BackgroundUnno, K., Tanida, N., Ishii, N., Yamamoto, H., Iguchi, K., Hoshino, M., Takeda, A., Ozawa, H., Ohkubo, T., Juneja, L. R., et al. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.09.004 · Cited by 72 · cited 1×
“The anti-stress effects of L-theanine (200 mg/day) have been observed following once- [33,34] and twice daily [35] administration, while its attention-improving effects have been observed in response to treatment of 100 mg/day on four separate days [36] and 200 mg/day single administration [37], which was further supp…”
BackgroundInfluentialUnno, K., Fujitani, K., Takamori, N., Takabayashi, F., Maeda, K.-I., Miyazaki, H., Tanida, N., Iguchi, K., Shimoi, K., & Hoshino, M. (2011) · Free Radical Research · doi:10.3109/10715762.2011.566869 · Cited by 72
Yamada, T., Terashima, T., Kawano, S., Furuno, R., Okubo, T., Juneja, L. R., & Yokogoshi, H. (2009) · Amino Acids · doi:10.1007/s00726-007-0020-7 · Cited by 71 · cited 2×
“The modulation of the monoamine [14–17] and glutamic acid and glycine [18,19] systems may also contribute to these four weeks psychotropic effects.”
BackgroundAcute Effects of Theanine, Caffeine and Theanine–Caffeine Combination on Attention
Kahathuduwa, C. N., Dassanayake, T. L., Amarakoon, A. M. T., & Weerasinghe, V. S. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1144845 · Cited by 71 · cited 1×
“The anti-stress effects of L-theanine (200 mg/day) have been observed following once- [33,34] and twice daily [35] administration, while its attention-improving effects have been observed in response to treatment of 100 mg/day on four separate days [36] and 200 mg/day single administration [37], which was further supp…”
BackgroundInfluentialIngestion of theanine, an amino acid in tea, suppresses psychosocial stress in mice
Unno, K., Iguchi, K., Tanida, N., Fujitani, K., Takamori, N., Yamamoto, H., Ishii, N., Nagano, H., Nagashima, T., Hara, A., et al. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.065532 · Cited by 69
Human disposition of L-theanine in tea or aqueous solution
van der Pijl, P. C., Chen, L., & Mulder, T. P. J. (2010) · Journal of Functional Foods · doi:10.1016/j.jff.2010.08.001 · Cited by 66 · cited 1×
“After a two-week wash-out period, which was justified based on the half-life of L-theanine plasma concentration reported around 65 min in humans [50], participants received the other tablets for a further four weeks, according to the crossover method.”
MethodBehavioral and molecular evidence for psychotropic effects in l-theanine
Wakabayashi, C., Numakawa, T., Ninomiya, M., Chiba, S., & Kunugi, H. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2440-z · Cited by 65 · cited 3×
“Furthermore, in behavioral experiments in mice, L-theanine has been reported to have anti-stress or antidepressant-like effects [22–26], which has been associated with an increase in the expression of brain-derived neurotrophic factor in the hippocampus [6], while anxiolytic effects of L-theanine have been observed in…”
BackgroundResultSelf-citationAntidepressant-like effects of l-theanine in the forced swim and tail suspension tests in mice
Yin, C., Gou, L., Liu, Y., Yin, X., Zhang, L., Jia, G., & Zhuang, X. (2011) · Phytotherapy Research · doi:10.1002/ptr.3456 · Cited by 63
In Search of a Safe Natural Sleep Aid
Rao, T. P., Ozeki, M., & Juneja, L. R. (2015) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.926153 · Cited by 59 · cited 1×
“In humans, L-theanine has been reported to modulate alpha activity and play a role in attentional tasks in electroencephalogram studies [28–30], as well as provide beneficial effects on mental state [31], including sleep quality [32].”
BackgroundSelf-citationProtective effect of l-theanine on chronic restraint stress-induced cognitive impairments in mice
Tian, X., Sun, L., Gou, L., Ling, X., Feng, Y., Wang, L., Yin, X., & Liu, Y. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.048 · Cited by 57
Effect of theanine on norepinephrine and serotonin levels in rat brain
KIMURA, R., & MURATA, T. (1986) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.34.3053 · Cited by 51
Kahathuduwa, C. N., Dhanasekara, C. S., Chin, S.-H., Davis, T., Weerasinghe, V. S., Dassanayake, T. L., & Binks, M. (2018) · Nutrition Research · doi:10.1016/j.nutres.2017.11.002 · Cited by 46 · cited 1×
“The anti-stress effects of L-theanine (200 mg/day) have been observed following once- [33,34] and twice daily [35] administration, while its attention-improving effects have been observed in response to treatment of 100 mg/day on four separate days [36] and 200 mg/day single administration [37], which was further supp…”
BackgroundInfluentialYokogoshi, H., & Terashima, T. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00384-1 · Cited by 45
Suzuki, T., Tsukamoto, K., & Abe, K. (2000) · Journal of Personality Assessment · doi:10.1207/s15327752jpa7403_8 · Cited by 38 · cited 4×
“The SDS, STAI-trait (T), and PSQI scores were significantly improved after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively; Figure 1).”
MethodInfluentialOgawa, S., Ota, M., Ogura, J., Kato, K., & Kunugi, H. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4743-1 · Cited by 37 · cited 2×
“Furthermore, in behavioral experiments in mice, L-theanine has been reported to have anti-stress or antidepressant-like effects [22–26], which has been associated with an increase in the expression of brain-derived neurotrophic factor in the hippocampus [6], while anxiolytic effects of L-theanine have been observed in…”
BackgroundResultSelf-citationTamano, H., Fukura, K., Suzuki, M., Sakamoto, K., Yokogoshi, H., & Takeda, A. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.02.005 · Cited by 33 · cited 2×
“studies [11,20,21] and our clinical trial for MDD [40], whereas they are inconsistent with the acute attention-improving effects reported in healthy humans [28–30,36–38].”
BackgroundResultTakeda, A., Tamano, H., Suzuki, M., Sakamoto, K., Oku, N., & Yokogoshi, H. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9732-z · Cited by 25 · cited 2×
“studies [11,20,21] and our clinical trial for MDD [40], whereas they are inconsistent with the acute attention-improving effects reported in healthy humans [28–30,36–38].”
BackgroundResultSebih, F., Rousset, M., Bellahouel, S., Rolland, M., de Jesus Ferreira, M. C., Guiramand, J., Cohen-Solal, C., Barbanel, G., Cens, T., Abouazza, M., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00036 · Cited by 24 · cited 2×
“L-theanine may act as a partial agonist for the N-methyl-D-aspartate receptor [5], resulting in its four weeks psychotropic (i.”
BackgroundTakarada, T., Nakamichi, N., Kakuda, T., Nakazato, R., Kokubo, H., Ikeno, S., Nakamura, S., Hinoi, E., & Yoneda, Y. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2014.12.018 · Cited by 19
Effect of L‐theanine on sensorimotor gating in healthy human subjects
Ota, M., Wakabayashi, C., Matsuo, J., Kinoshita, Y., Hori, H., Hattori, K., Sasayama, D., Teraishi, T., Obu, S., Ozawa, H., et al. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12134 · Cited by 16 · cited 1×
“This dose was chosen because it was found to be effective in a previous study [48], which was normal dose as also used in other studies [33–35,37].”
ResultSelf-citationNathan, P. J., Lu, K., Gray, M., & Oliver, C. (2006) · Journal of Herbal Pharmacotherapy · doi:10.1080/j157v06n02_02 · cited 2×
“studies [11,20,21] and our clinical trial for MDD [40], whereas they are inconsistent with the acute attention-improving effects reported in healthy humans [28–30,36–38].”
BackgroundResultJin (1998) · doi:10.1002/(sici)1097-4679(199806)54:4
Untitled work
Nobre (2008) · doi:10.6133/apjcn.2008.17.s1.40
Research works printed but not linked: 1
- Spielberg, C.D. (1970). STAI Manual, Consulting Psychologists Press.
Cited by
Li, M.-Y., Liu, H.-Y., Wu, D.-T., Kenaan, A., Geng, F., Li, H.-B., Gunaratne, A., Li, H., & Gan, R.-Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.853846 · Cited by 128
Fatima, M. T., Bhat, A. A., Nisar, S., Fakhro, K. A., & Akil, A. A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12698 · Cited by 127
“Aminoacid Green tea, black tea, certain mushrooms In vitro In vivo Human [35] [36,37] [38,39]”
BackgroundHow does the tea L-theanine buffer stress and anxiety
Wang, L., Brennan, M., Li, S., Zhao, H., Lange, K. W., & Brennan, C. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.12.004 · Cited by 80
Green Tea Suppresses Brain Aging
Unno, K., & Nakamura, Y. (2021) · Molecules · doi:10.3390/molecules26164897 · Cited by 79
Xu, T., Ye, X., Lu, X., Lan, G., Xie, M., Huang, Z., Wang, T., Wu, J., Zhan, Z., & Xie, X. (2023) · Environment International · doi:10.1016/j.envint.2023.107803 · Cited by 79
Metadata
- Authors
- Hidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H.
- Affiliations
- National Center of Neurology and Psychiatry (JP)
- Taiyo Kagaku Co., Ltd. (Japan) (JP)
- Corresponding author
- Kunugi, Hiroshi
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-10-03
- Volume
- 11
- Issue
- 10
- Pages
- 2362
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6836118
- OpenAlex
- W2977908783
- Semantic Scholar
- a77bb6ac85035be83ec02a7b6eee6ea31c929676
- Cited by
- 170
- References
- 65
- Citations by year
- 2026: 32 · 2025: 38 · 2024: 34 · 2023: 23 · 2022: 18 · 2021: 17 · 2020: 8
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Funding received from Taiyo Kagaku Co., Ltd., Mie, Japan. (None)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- theanine, stress-related symptoms, cognitive function, depression, anxiety, sleep quality, sleep latency, sleep disorders, sleep medication use, verbal fluency, phonemic fluency, executive function, healthy adults, mental health
- MeSH terms
- Adult, Anxiety, Cognition, Depression, Double-Blind Method, Female, Glutamates, Humans, Male, Middle Aged, Placebos, Sleep Wake Disorders, Stress, Psychological, Body Mass Index, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.